Skip to content

The Correlation Between Hair Cortisol Level of Acute Stroke or Its Long Term Disability.

The Correlation Between Hair Cortisol Level of Acute Stroke or Its Long Term Disability.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02587949
Enrollment
30
Registered
2015-10-27
Start date
2015-11-30
Completion date
2019-11-30
Last updated
2018-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Stroke

Keywords

acute cerebrovascular stroke

Brief summary

In patients admitted to hospital with acute cerebrovascular stroke, we want to study the relationship between hair cortisol levels and biomarkers of inflammation and the clinical and radiological severity of the stroke and the degree of neurological disability being tested in three months and one year after.

Detailed description

The study will include patients hospitalized due to an acute cerebrovascular stroke. A number of 30 patients aged 40-70 will be included. Within 48 hours of the event, blood inflammatory biomarkers, and scalp hair sample for cortisol will be taken. All recruited patients will undergo full neurological examination and the severity of the stroke will be rated using NIHSS (National Institutes of Health Stroke Scale). 3 months and one year later neurological examination and rating of neurological disability will be determined using Rankin Scale.

Interventions

None listed

Sponsors

Bnai Zion Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients aged 40-80. 2. Acute cerebrovascular stroke (symptoms that began no more than 72 hours before) 3. Rankin 0-1 before the event

Exclusion criteria

1. Suspicion or known Cushing's syndrome 2. Known adrenal failure 3. Chronic inflammatory disease 4. Active malignancy 5. Acute infectious disease within 4 months before enrollment

Design outcomes

Primary

MeasureTime frameDescription
INL-624 monthssingle blood sample will be drawn to measure INL-6 levels.
Anti Tumor Necrosis Factor alpha24 monthssingle blood sample will be drawn to measure Anti Tumor Necrosis Factor alpha levels (pg/ml).
C-reactive protein levels24 monthssingle blood sample will be drawn to measure c-reactive protein levels (mcg/dl).
Hair Cortisol level24 monthssingle hair sample will be drawn to measure cortisol levels (mcg/dl)

Secondary

MeasureTime frameDescription
TSH24 monthssingle blood sample will be drawn to measure Thyroid-Stimulating Hormone (mcIU/ml).
FT424 monthssingle blood sample will be drawn to measure Free Thyroxine (pmol/L) .
FT324 monthssingle blood sample will be drawn to measure Free Triiodothyronine (pmol/L).
Cortisol24 monthssingle blood sample will be drawn to measure cortisol levels (mcg/dl).

Countries

Israel

Contacts

Primary ContactMira Koch
mira.koch@b-zion.org.il97248359351
Backup ContactMichal Yeiches
yeiches@gmail.com97248359484

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026